Effective hyperbaric oxygenation with prostaglandin E1 for radiation cystitis and colitis after pelvic radiotherapy

1996 ◽  
Vol 28 (5) ◽  
pp. 643-647 ◽  
Author(s):  
M. Miura ◽  
I. Sasagawa ◽  
Y. Kubota ◽  
Y. Iijima ◽  
T. Sawamura ◽  
...  
Keyword(s):  
Prostaglandin E1 ◽  
Hyperbaric Oxygenation ◽  
Pelvic Radiotherapy ◽  
Radiation Cystitis

scholarly journals Hyperbaric oxygen therapy for radiation cystitis after pelvic radiotherapy: Systematic review of the recent literature

2019 ◽  
Vol 27 (2) ◽  
pp. 98-107 ◽  
Author(s):  
Lauren Villeirs ◽  
Thomas Tailly ◽  
Piet Ost ◽  
Marjan Waterloos ◽  
Karel Decaestecker ◽  
...  
Keyword(s):  
Systematic Review ◽  
Hyperbaric Oxygen ◽  
Hyperbaric Oxygen Therapy ◽  
Oxygen Therapy ◽  
Recent Literature ◽  
Pelvic Radiotherapy ◽  
Radiation Cystitis

Current management of radiation cystitis after pelvic radiotherapy: a systematic review

2021 ◽  
Author(s):  
Michele MARCHIONI ◽  
Piergustavo DE FRANCESCO ◽  
Riccardo CAMPI ◽  
Umberto CARBONARA ◽  
Matteo FERRO ◽  
...  
Keyword(s):  
Systematic Review ◽  
Pelvic Radiotherapy ◽  
Current Management ◽  
Radiation Cystitis

Successful Hyperbaric Oxygenation for Radiation Cystitis due to Excessive Irradiation to Uterus Cancer

1992 ◽  
Vol 22 (4) ◽  
pp. 294-297 ◽  
Author(s):  
Teruhiro Nakada ◽  
Toshiyuki Yamaguchi ◽  
Isoji Sasagawa ◽  
Yoko Kubota ◽  
Hotoshi Suzuki ◽  
...  
Keyword(s):  
Hyperbaric Oxygenation ◽  
Radiation Cystitis ◽  
Excessive Irradiation

scholarly journals Urinary infection or radiation cystitis? A prospective evaluation of urinary symptoms in patients submitted to pelvic radiotherapy

Clinics ◽  
2019 ◽  
Vol 74 ◽  
Author(s):  
Vítor Fonseca Xavier ◽  
Flávia Carolina Grosso Gabrielli ◽  
Karim Yaqub Ibrahim ◽  
Mariana Vilela Soares Gomes ◽  
Roger Guilherme Rodrigues Guimarães ◽  
...  
Keyword(s):  
Urinary Infection ◽  
Urinary Symptoms ◽  
Prospective Evaluation ◽  
Pelvic Radiotherapy ◽  
Radiation Cystitis

scholarly journals Urinary infection or radiation cystitis? A prospective evaluation of urinary symptoms in patients submitted to pelvic radiotherapy

Clinics ◽  
2019 ◽  
Vol 74 ◽  
Author(s):  
Vítor Fonseca Xavier ◽  
Flávia Carolina Grosso Gabrielli ◽  
Karim Yaqub Ibrahim ◽  
Mariana Vilela Soares Gomes ◽  
Roger Guilherme Rodrigues Guimarães ◽  
...  
Keyword(s):  
Urinary Infection ◽  
Urinary Symptoms ◽  
Prospective Evaluation ◽  
Pelvic Radiotherapy ◽  
Radiation Cystitis

64: Intravesical Instillation of Epinephrine in Patients with Intractable Hemorrhagic Cystitis Due to Radiation Cystitis

2007 ◽  
Vol 177 (4S) ◽  
pp. 22-22
Author(s):  
Yung C. Chow ◽  
Jong M. Hsu ◽  
Wen C. Lin ◽  
Huang K. Chang ◽  
Yuh C. Yang ◽  
...  
Keyword(s):  
Hemorrhagic Cystitis ◽  
Intravesical Instillation ◽  
Radiation Cystitis

Ticlopidine Facilitates the Deaggregation of Human Platelets Aggregated by Thrombin

1994 ◽  
Vol 71 (01) ◽  
pp. 091-094 ◽  
Author(s):  
M Cattaneo ◽  
B Akkawat ◽  
R L Kinlough-Rathbone ◽  
M A Packham ◽  
C Cimminiello ◽  
...  
Keyword(s):  
Cardiovascular Disease ◽  
Platelet Aggregation ◽  
Prostaglandin E1 ◽  
Human Platelet ◽  
Adenosine Diphosphate ◽  
Human Platelets ◽  
Before And After ◽  
Normal Human ◽  
Platelet Aggregates ◽  
Induced Aggregation

SummaryNormal human platelets aggregated by thrombin undergo the release reaction and are not readily deaggregated by the combination of inhibitors hirudin, prostaglandin E1 (PGE1) and chymotrypsin. Released adenosine diphosphate (ADP) plays an important role in the stabilization of thrombin-induced human platelet aggregates. Since ticlopidine inhibits the platelet responses to ADP, we studied thrombin-induced aggregation and deaggregation of 14C-serotonin-labeled platelets from 12 patients with cardiovascular disease before and 7 days after the oral administration of ticlopidine, 250 mg b.i.d. Before and after ticlopidine, platelets stimulated with 1 U/ml thrombin aggregated, released about 80–90% 14C-serotinin and did not deaggregate spontaneously within 5 min from stimulation. Before ticlopidine, hirudin (5× the activity of thrombin) and PGE1 (10 μmol/1) plus chymotrypsin (10 U/ml) or plasmin (0.06 U/ml), added at the peak of platelet aggregation, caused slight or no platelet deaggregation. After ticlopidine, the extent of platelet deaggregation caused by the same inhibitors was significantly greater than before ticlopidine. The addition of ADP (10 μmol/1) to platelet suspensions 5 s after thrombin did not prevent the deaggregation of ticlopidine-treated platelets. Thus, ticlopidine facilitates the deaggregation of thrombin-induced human platelet aggregates, most probably because it inhibits the effects of ADP on platelets.

Sign in / Sign up

Export Citation Format

Share Document